semaglutide saxenda EU investigates Ozempic, weight-loss drug after suicidal thoughts reported Saxenda (liraglutide) for Weight Loss

Hongxia et al 148 performed an RCT of 104 patients with neurogenic tinnitus associated with liver qi stagnation

Regulatory scrutiny has intensified, and the FDA has stepped in to limit many uses

GLP-1 analogs, new trend in obesity treatment, become even more effective Eli Lilly Korea names John Bickel as new GM Lilly Koreas new atopic dermatitis drug Ebglyss' receives approval Newly diagnosed diabetes during hospitalization affects mortality, length of stay Dont give up life-saving statin drugs just because of concerns Mounjaro praised as super GLP-1, sparking interest in Korean launch, insurance coverage Eli Lilly launches atopic dermatitis drug Ebglyss in Korea Korean Diabetes Association removes metformin as preferred first-line therapy in latest guidelines Lee Han-soo [email protected]

The world is inconvenient like that

Saxenda tiene eficacia menor (~5-7% peso) que semaglutida o tirzepatida (14.9% en STEP-1 , 22.5% en SURMOUNT-1 )